Members |
targetComponentId |
Diff. white cell count NOS |
Differential white blood cell count procedure (procedure) |
Diff. white cell count NOS |
Differential white blood cell count procedure (procedure) |
vanskelig intubation |
Difficult intubation |
besvær med at tale |
Difficulty talking |
nodalt/systemisk diffust storcellet B-celle-lymfom med hudinvolvering |
Diffuse large B-cell malignant lymphoma (disorder) |
diffust storcellet B-celle-lymfom iht. kategori |
Diffuse large B cell malignant lymphoma (morphologic abnormality) |
diffus Brocqs neurodermatit |
Atopic dermatitis (disorder) |
Diffuse non-Hodgkin's lymphoblastic (diffuse) lymphoma |
Precursor cell lymphoblastic lymphoma |
lymfoblastært non-Hodgkin-lymfom af diffus type |
Precursor cell lymphoblastic lymphoma |
diffus unilateral subakut neuroretinit |
Diffuse unilateral subacute neuroretinitis |
diflucan oral suspension |
Fluconazole-containing product in oral dose form |
Difluprednate 0.05% ophthalmic emulsion |
Difluprednate 500 microgram/mL eye suspension |
fordøjelsesmiddel |
Digestant (substance) |
endoskop til fordøjelseskanalen |
Endoscope |
Digestive function tests NOS |
Digestive function tests |
Digestive function tests NOS |
Digestive function tests |
Digestive system diseases NOS |
Disorder of digestive system (disorder) |
Digestive system diseases NOS |
Disorder of digestive system (disorder) |
Digoxin 38mg/vial injection |
Digoxin immune fab only product |
digoxin-antistof Fab-fragment 38 mg/hætteglas, pulver til injektionsvæske, 4 ml hætteglas |
Digoxin immune fab only product |
digoxinspecifikt antistof 38 mg pulver til injektionsvæske, opløsning, hætteglas |
Digoxin immune fab only product |
antipsykotisk dihydrocarbostyrilderivatmiddel |
Dihydrocarbostyril derivative |
dihydroergotaminmesylat 1 mg/ml injektionsvæske, opløsning, ampul |
Product containing precisely dihydroergotamine mesilate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
dihydroergotaminmesylat 4 mg/1 ml næsespray |
Product containing precisely dihydroergotamine mesilate 500 microgram/1 actuation conventional release nasal spray (clinical drug) |
allergi over for dihydroergotaminmesylat |
Allergy to dihydroergotamine |
Dihydrofolate reductase deficiency |
Deficiency of dihydrofolate reductase |
antipsykotisk dihydroindolonderivatmiddel |
Dihydroindolone derivative (substance) |
dihydrotachysterol 0,2 mg/ml |
Product containing dihydrotachysterol (medicinal product) |
dihydrotachysterol 170 mg |
Product containing dihydrotachysterol (medicinal product) |
Dilatation og curettage, ikke nærmere specificeret |
Dilation and curettage |
Dilatation and curettage NOS |
Dilation and curettage |
Dilatation of gastrointestinal tract NOS |
Dilation of gastrointestinal tract |
Dilatation of gastrointestinal tract NOS |
Dilation of gastrointestinal tract |
Dilatation: [other opening] or [non GIT] |
Dilation procedure |
Dilatation: [other opening] or [non GIT] |
Dilation procedure |
Dilatation af cervix uteri og curettage af uterus, ikke klassificeret andetsteds |
Dilation and curettage of uterus |
Dilation of cervix uteri and curettage of uterus NEC |
Dilation and curettage of uterus |
Dilatation af cervix uteri og evakuering af graviditetsprodukt fra uterus, ikke klassificeret andetsteds |
Evacuation of retained product of conception |
Dilation of colon |
Dilation of colon |
Dilation of colostomy stoma |
Dilation of colostomy stoma |
Dilation of mature percutaneous transhepatic biliary drainage tract under radiological guidance |
Fluoroscopy guided dilation of mature percutaneous transhepatic biliary drainage tract |
Dilation of organ NOC |
Dilation procedure |
Dilation of organ NOC NOS |
Dilation procedure |
Dilation of stricture of organ NOC |
Dilation procedure |
diltiazem 180 mg tablet med modificeret udløsning |
Diltiazem only product in oral dose form |
Diltiazem 180mg prolonged-release oral tablet |
Diltiazem only product in oral dose form |
diltiazem 240 mg tablet med modificeret udløsning |
Diltiazem only product in oral dose form |
Diltiazem 240mg prolonged-release oral tablet |
Diltiazem only product in oral dose form |
diltiazem 300 mg tablet med modificeret udløsning |
Diltiazem only product in oral dose form |
Diltiazem 300mg prolonged-release oral tablet |
Diltiazem only product in oral dose form |
Diltiazem 360mg m/r tablet |
Diltiazem only product in oral dose form |
Diltiazem 360mg prolonged-release oral tablet |
Diltiazem only product in oral dose form |
diltiazem 420 mg tablet med modificeret udløsning |
Diltiazem only product in oral dose form |
Diltiazem 420mg prolonged-release oral tablet |
Diltiazem only product in oral dose form |
diltiazemhydrochlorid 420 mg kapsel med modificeret udløsning |
Diltiazem only product in oral dose form |
Diltiazem hydrochloride 420mg prolonged-release oral capsule |
Diltiazem only product in oral dose form |
diltiazemhydrochlorid 5 mg/ml opløsning |
Product containing only diltiazem in parenteral dose form (medicinal product form) |
Dimeglumine gadopentetate |
Product containing gadopentetic acid (medicinal product) |
Dimeglumine gadopentetate |
Product containing gadopentetic acid (medicinal product) |
dimeglumingadopentetat 469,01 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte |
Gadopentetic acid only product |
dimeglumingadopentetat 469,01 mg/ml injektionsvæske, opløsning, hætteglas |
Gadopentetic acid only product |
Dingo dog breed |
Canis lupus dingo |
Dinoprostone 10mg insert |
Dinoprostone 10 mg prolonged-release vaginal pessary |
dinoproston 10 mg vagitorium |
Dinoprostone 10 mg prolonged-release vaginal pessary |
dinoproston 10 mg/ml koncentrat til infusionsvæske, ampul a 0,5 ml |
Dinoprostone 10 mg/mL solution for injection |
dinoproston 1 mg/ml koncentrat til infusionsvæske, ampul a 0,75 ml |
Dinoprostone 1 mg/mL solution for injection |
Dioxygenase |
Dioxygenase (substance) |
Dipeptide hydrolase |
Dipeptide hydrolase |
Dipeptidylcarboxypeptidase II |
Dipeptidyl carboxypeptidase II (substance) |
Dipeptidylpeptide hydrolase |
Dipeptidylpeptide hydrolase |
Dipetalonema perstans |
Mansonella perstans |
diphenhydramin 2 % + zinkacetat 0,1 % creme til topikal anvendelse |
Diphenhydramine hydrochloride 20 mg/mL and zinc acetate 1 mg/mL cutaneous cream |
diphenhydraminhydrochlorid eliksir 12,5 mg/5 ml |
Product containing precisely diphenhydramine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
diphenhydraminhydrochlorid 12,5 mg/5 ml syrup |
Product containing precisely diphenhydramine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Diphenhydramine hydrochloride 6.25mg/5mL syrup |
Diphenhydramine hydrochloride 1.25 mg/mL oral solution |
diphenhydraminhydrochlorid 6,25 mg/5 ml syrup |
Diphenhydramine hydrochloride 1.25 mg/mL oral solution |
difenylmethandiisocyanat-specifikt ekstrakt |
Diphenylmethane di-isocyanate |
Diphtheria and tetanus double vaccination NOS |
Administration of diphtheria and tetanus vaccine |
dobbeltvaccination mod difteri og stivkrampe, ikke nærmere specificeret |
Administration of diphtheria and tetanus vaccine |
difteritoxin til kutantest |
Diphtheria toxin |
Diphtheria vaccination NOS |
Administration of diphtheria vaccine |
difterivaccination, ikke nærmere specificeret |
Administration of diphtheria vaccine |
Diphtheria, pertussis and tetanus triple vaccination |
Administration of diphtheria, pertussis, and tetanus vaccine |
Diphtheria, pertussis and tetanus triple vaccination NOS |
Administration of diphtheria, pertussis, and tetanus vaccine |
vaccination mod difteri, kighoste og stivkrampe, ikke nærmere specificeret |
Administration of diphtheria, pertussis, and tetanus vaccine |
dipivefrinhydrochlorid 0,1 % øjendråber |
Dipivefrine hydrochloride 1 mg/mL eye solution |
Dipivefrin hydrochloride 0.1% ophthalmic solution |
Dipivefrine hydrochloride 1 mg/mL eye solution |
Dipivefrin hydrochloride 0.1%wv solution |
Dipivefrine hydrochloride 1 mg/mL eye solution |
Direct inguinal hernia NOS |
Direct inguinal hernia (disorder) |
direkte ingvinalhernie, ikke nærmere specificeret |
Direct inguinal hernia (disorder) |
Direkte indvækst i binyre (T3a) |
American Joint Committee on Cancer cT3a (qualifier value) |
Direkte laryngoskopi med injektion i stemmelæbe, terapeutisk |
Direct laryngoscopy with injection into vocal cord (procedure) |
Direkte laryngoskopi, diagnostisk, nyfødt |
Direct laryngoscopy |
Direkte diagnostisk laryngoskopi med operationsmikroskop |
Direct laryngoscopy with operating microscope (procedure) |
kolangiografi ved direkte peroperativ punktur |
Intraoperative fluoroscopic cholangiography by direct puncture with contrast (procedure) |
Director/producer/manager NOS |
Directors/producers/managers |
Director/producer/manager NOS |
Directors/producers/managers |
Dirty environment |
Dirty environment (finding) |
Disabled driver report NOS |
Disabled driver report status (finding) |
Disabled driver report NOS |
Disabled driver report status (finding) |
Disabled registration application - NOS |
Disabled registration application status |